Episodes

  • Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025

    Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025
    Jun 25 2025

    On the latest episode of the Optimum Perspectives podcast, Optimum Strategic Communications’ Managing Director Eva Haas spoke with Curve Therapeutics CSO and Co-Founder Ali Tavassoli, who has today been awarded the Royal Society of Chemistry’s Interdisciplinary Prize.

    Listen below as Ali reflects on his scientific journey which has led him to this tremendous recognition, from what inspired his passion for science, to how he came to meet Curve CEO Simon Kerry, with whom he co-founded the Company. Curve’s is using its revolutionary gene-encoded Microcycle® platform to build a pipeline of innovative cyclic peptide and small molecule drugs addressing intracellular targets, with a focus on cancer, immunology and inflammation.



    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    24 mins
  • Stronger together: changing the future of muscle wasting condition

    Stronger together: changing the future of muscle wasting condition
    Feb 28 2025

    Listen to our Rare Disease Day Optimum Perspecitives podcast special featuring Tahira Mathur, Patient Advocate and Kate Adcock, Director of Research & Innovation at Optimum's chosen charity Muscular Dystrophy UK, alongside Jasper Morrow, consultant neurologist at University College London Hospital.

    This emotional yet hopeful episode highlights the importance of raising awareness of rare conditions, while discussing patient care, diagnosis, and genetic testing for Muscular Dystrophy.

    If you would like to contribute to the life changing work of Muscular Dystrophy UK, or find out more about Tahira's story living with GNE myopathy, visit her page here: Tahira's Team - JustGiving



    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    30 mins
  • How bioengineered spider silk-based proteins are changing the world

    How bioengineered spider silk-based proteins are changing the world
    Feb 6 2025

    Want to know how bioengineered spider silk protein fibres can be applied within the textile, biomedical and automobile industries?

    In the latest episode of Optimum Perspectives, hear from Benoit Cugnet, Head of Fiber Business Unit at AMSilk, on how this German biotech is changing the face of advanced materials.


    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    12 mins
  • How to have a perfect IPO on NASDAQ

    How to have a perfect IPO on NASDAQ
    Jan 23 2025

    Want to know how to prepare yourself for the perfect IPO on NASDAQ?

    Hear from Lynn Lewis, CEO of Gilmartin Group, Optimum’s US partner, on the considerations and milestones to reach before listing.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    24 mins
  • Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

    Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers
    Nov 27 2024
    The latest epiosde of Optimum Perspectives Podcast features Germo Gericke, CMO of Ariceum Therapeutics. Listen as he discusses how the company aims to improve outcomes for patients with lung cancer with radioligand therapy this Lung Cancer Awareness Month.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    10 mins
  • Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer

    Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer
    Nov 21 2024
    Great new insights in the Optimum Perspectives' latest podcast edition featuring Stefano Gullà, Chief Scientific Officer at Kling Biotherapeutics, about the growing role of B cell technology in cancer therapy.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    9 mins
  • DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

    DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology
    Nov 5 2024
    In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    16 mins
  • SpliceBio: Celebrating progress in ophthalmology research on World Sight Day

    SpliceBio: Celebrating progress in ophthalmology research on World Sight Day
    Oct 10 2024
    Optimum’s Richard Staines talks to Feride Sahin, Senior Director of Clinical Development at Splice Bio about the importance of World Sight Day, which takes place this week.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    12 mins